IDH2 and prostate carcinoma: The three-fold decrease in IDH2 expression normalised the TCA cycle in prostate cancer cells, and the 4.3-fold increase in FH expression inhibited fumarate build-up in prostate cancer cells and deactivated the angiogenic factor hypoxia-inducible factor 1-alpha (Figure 7).